12.08
6.93%
-0.90
After Hours:
12.36
0.28
+2.32%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Lifevantage Corporation stock is traded at $12.08, with a volume of 154.12K.
It is down -6.93% in the last 24 hours and up +51.76% over the past month.
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
See More
Previous Close:
$12.98
Open:
$12.9
24h Volume:
154.12K
Relative Volume:
1.79
Market Cap:
$158.05M
Revenue:
$212.99M
Net Income/Loss:
$2.56M
P/E Ratio:
60.40
EPS:
0.2
Net Cash Flow:
$9.47M
1W Performance:
+15.38%
1M Performance:
+51.76%
6M Performance:
+99.67%
1Y Performance:
+87.29%
Lifevantage Corporation Stock (LFVN) Company Profile
Name
Lifevantage Corporation
Sector
Industry
Phone
801-432-9000
Address
3300 TRIUMPH BLVD, LEHI
Lifevantage Corporation Stock (LFVN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-08-14 | Initiated | Midtown Partners | Buy |
Feb-12-14 | Initiated | Imperial Capital | In-line |
Lifevantage Corporation Stock (LFVN) Latest News
Subdued Growth No Barrier To LifeVantage Corporation (NASDAQ:LFVN) With Shares Advancing 63% - Simply Wall St
LifeVantage GLP-1: Hoping To Change Things Up In The Weight-Management Space (NASDAQ:LFVN) - Seeking Alpha
LifeVantage Co. (NASDAQ:LFVN) Sees Significant Growth in Short Interest - MarketBeat
LifeVantage concludes GLP-1 weight management trial - Investing.com
LifeVantage completes human clinical trial with new GLP-1 system - TipRanks
LifeVantage Completes Successful Human Clinical Trial with New GLP-1 System for Activated Weight Loss* † - GlobeNewswire
LifeVantage Completes Successful Human Clinical Trial with New GLP-1 System for Activated Weight Loss* † - StockTitan
LifeVantage Corporation's (NASDAQ:LFVN) market cap rose US$21m last week; retail investors who hold 51% profited and so did insiders - Simply Wall St
LifeVantage stock soars to 52-week high, hits $10.97 By Investing.com - Investing.com Australia
LifeVantage stock soars to 52-week high, hits $10.97 - Investing.com
LifeVantage stock soars to 52-week high, hits $10.97 By Investing.com - Investing.com UK
Investors in LifeVantage (NASDAQ:LFVN) have seen notable returns of 69% over the past year - Yahoo Finance
(LFVN) Trading Advice - Stock Traders Daily
LifeVantage stock soars to 52-week high, hits $10.48 By Investing.com - Investing.com Australia
LifeVantage stock soars to 52-week high, hits $10.48 - Investing.com India
LifeVantage stock soars to 52-week high, hits $10.48 By Investing.com - Investing.com UK
Where are the Opportunities in (LFVN) - Stock Traders Daily
LFVNLifevantage Corporation Latest Stock News & Market Updates - StockTitan
LifeVantage Announces Positive In Vitro Results for New - GlobeNewswire
LifeVantage reports GLP-1 production boost in study - Investing.com
LifeVantage Announces Positive In Vitro Results for New GLP-1 System Showing Synergistic Gene Activation for Enhanced Weight Management* † - StockTitan
LIFEVANTAGE CORPORATION - Marketscreener.com
LifeVantage stock soars to 52-week high, hits $9.17 By Investing.com - Investing.com Canada
LifeVantage stock soars to 52-week high, hits $9.17 - Investing.com
LifeVantage Jumps on Bringing Lemonade Permanently - MSN
Here's Why We're Wary Of Buying LifeVantage's (NASDAQ:LFVN) For Its Upcoming Dividend - Simply Wall St
Lifevantage director Garry Paul Mauro buys $11,848 in company stock - Investing.com
Lifevantage director Garry Paul Mauro buys $11,848 in company stock - Investing.com India
Lifevantage director Garry Paul Mauro buys $11,848 in company stock By Investing.com - Investing.com UK
We Think LifeVantage's (NASDAQ:LFVN) Solid Earnings Are Understated - Simply Wall St
LifeVantage to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
LifeVantage to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
LifeVantage Jumps on Bringing Lemonade Permanently - Baystreet.ca
LifeVantage Welcomes Back AXIO® Lemonade—Now As a Permanent Flavor - GlobeNewswire
LifeVantage Welcomes Back AXIO® Lemonade—Now As a Permanent Flavor - StockTitan
Lifevantage Corporation [LFVN] Investment Guide: What You Need to Know - Knox Daily
Investors in cash trouble should check out Lifevantage Corporation (LFVN) - SETE News
Lifevantage Corporation (LFVN)’s stock rises to 7.96 per share - US Post News
LifeVantage (NASDAQ:LFVN) Releases Quarterly Earnings Results, Misses Estimates By $0.07 EPS - MarketBeat
LifeVantage Co. (NASDAQ:LFVN) Plans $0.04 Quarterly Dividend - MarketBeat
Q4 2024 LifeVantage Corp Earnings Call - Yahoo Finance UK
Lifevantage Shares Fall on Lower 4Q Earnings - MarketWatch
LifeVantage Corporation (NASDAQ:LFVN) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call: LifeVantage shows resilience with stable margins amid revenue dip - Investing.com Canada
Earnings call: LifeVantage shows resilience with stable margins amid revenue dip - Investing.com
Earnings call: LifeVantage shows resilience with stable margins amid revenue dip - Investing.com India
Earnings call: LifeVantage shows resilience with stable margins amid revenue dip - Investing.com UK
Lifevantage Corp (LFVN) Q4 2024 Earnings Call Transcript Highlig - GuruFocus.com
Lifevantage: Fiscal Q4 Earnings Snapshot - mySA
Lifevantage: Fiscal Q4 Earnings Snapshot - San Antonio Express-News
Lifevantage: Fiscal Q4 Earnings Snapshot - New Haven Register
Lifevantage Corporation Stock (LFVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):